Chimeric antigen receptor T cell therapy (CAR-T cell therapy) is a new kind of immunotherapy with encouraging results in the treatment of hematological malignancies. At present, CD19 is the most ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback